Qube Research & Technologies (QRT)’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,045,255
| Closed | -$7.76M | – | 3577 |
|
|
2024
Q1 | $7.76M | Buy |
1,045,255
+661,810
| +173% | +$4.91M | 0.01% | 838 |
|
|
2023
Q4 | $3.88M | Buy |
+383,445
| New | +$3.88M | 0.01% | 980 |
|
|
2023
Q3 | – | Sell |
-250,991
| Closed | -$2.07M | – | 3701 |
|
|
2023
Q2 | $2.07M | Buy |
250,991
+84,209
| +50% | +$693K | 0.01% | 974 |
|
|
2023
Q1 | $1.21M | Buy |
166,782
+133,705
| +404% | +$969K | 0.01% | 1151 |
|
|
2022
Q4 | $293K | Sell |
33,077
-114,852
| -78% | -$1.02M | ﹤0.01% | 1584 |
|
|
2022
Q3 | $1.81M | Buy |
+147,929
| New | +$1.81M | 0.01% | 923 |
|
|
2022
Q2 | – | Sell |
-18,708
| Closed | -$356K | – | 2630 |
|
|
2022
Q1 | $356K | Sell |
18,708
-8,103
| -30% | -$154K | ﹤0.01% | 1676 |
|
|
2021
Q4 | $712K | Buy |
26,811
+5,470
| +26% | +$145K | 0.01% | 1384 |
|
|
2021
Q3 | $877K | Buy |
+21,341
| New | +$877K | 0.01% | 955 |
|
|
2021
Q2 | – | Sell |
-15,486
| Closed | -$650K | – | 2382 |
|
|
2021
Q1 | $650K | Buy |
+15,486
| New | +$650K | 0.01% | 1025 |
|
|
2020
Q4 | – | Sell |
-17,108
| Closed | -$480K | – | 1896 |
|
|
2020
Q3 | $480K | Buy |
+17,108
| New | +$480K | 0.01% | 1047 |
|
|
2020
Q1 | – | Sell |
-35,987
| Closed | -$1.07M | – | 1250 |
|
|
2019
Q4 | $1.07M | Buy |
+35,987
| New | +$1.07M | 0.03% | 582 |
|